Source: Sharyl Attkisson

A recent study published in the American Journal of Therapeutics gives a hearty endorsement to the effectiveness of the drug ivermectin in treating Covid-19.

The study finds:

  • Large reductions in Covid-19 deaths are possible using ivermectin
  • Using ivermectin early may reduce the numbers progressing to severe disease
  • Ivermectin is low cost

Together, the study finds, ivermectin can have a “significant impact” on the Covid-19 epidemic.

Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.

American Journal of Therapeutics





Related: Ivermectin for Prevention and Treatment of COVID-19 Infection

Journal Editors Resign Over Suppression of Ivermectin Research Paper – The Chloroquine Wars Part XXVII

Everything Bret Weinstein, Heather Heying, and Pierre Kory Missed About “The Crime of the Century” The Chloroquine Wars Part XXVI

INDIA: Mumbai Move for Ivermectin Prophylaxis While Uttar Pradesh Smashes COVID-19 but Drug’s Use Suppressed in Media

Widespread distribution of ivermectin proves effective in Mexico against COVID-19

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

A Conversation With Dr. Brian Tyson – The Chloroquine Wars Part XLI

The data from the vaccine trials must be recalculated under the lens that some of the serious adverse events (SAEs) should be treated as COVID-19 cases.
There may not be any vaccine efficacy in the data at all if some of the post-vaccination deaths are due to vaccine-induced COVID-19. It could even be the case that the mortality efficacy goes negative. My implied lives saved calculations put this easily in the realm of possibility. The only way to know is for authorities to organize and compile the data. And while a risk analysis is certainly due after more than six months of hundreds of millions of doses delivered, there is little indication authorities have bothered with the process. That’s more than a bit unsettling.

Read More »

Dr. Brian Tyson, USA: Hydroxychloroquine – Data, Strategies and Success Treating over 6000 Covid Patients

We continue to delve extensively into the COVID-19 data with esteemed statistician, Mathew Crawford. In this episode, we take a closer look at the use of early treatment and its success. Mathew has been researching the data from Dr. Brian Tyson, who has successfully treated over 6000 patients who contracted COVID throughout the pandemic. It is my great honor to have Dr. Tyson here on this episode to not only discuss the data, but also the strategies that he has been using throughout the pandemic.

Read More »